Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
BBC Russian Subscribe
Spotlight

COPD

The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.

Latest News
September 6th 2024

Roflumilast Linked to Higher 5-Year Mortality in Patients With COPD in US, Germany

August 20th 2024

Study: Most Patients With COPD Remain Untreated Following Initial Diagnosis

August 15th 2024

Malnutrition in Older Patients With COPD Linked to Higher Hospital Readmission Rates

August 10th 2024

Medicare Advantage Program Linked to Higher Inhaler Adherence in Patients With COPD

August 7th 2024

Poor Socioeconomic Status Linked to Higher COPD Risk in Chinese Adults, Study Finds

Video Interviews
View All
June 8th 2024

Dr Surya Bhatt on Dupilumab's Promise in Reducing COPD Exacerbations, Enhancing Quality of Life

June 1st 2024

Dr Surya Bhatt Highlights NOTUS Trial Findings, Promising Dupilumab Results

June 2nd 2023

Dr Surya Bhatt Discusses the Role of Dupilumab in Type 2 Inflammation, Exacerbations in COPD

May 22nd 2023

Dr Debra Boyer: Childhood Respiratory Illness Impacts Adult Health

January 18th 2023

Key Takeaways and Considerations Surrounding COPD Therapies

January 18th 2023

Cost Drivers Impacting Treatment Strategies for COPD

January 11th 2023

Role of Non-Medication Strategies in COPD Treatment Pathway

January 11th 2023

Individualizing Medication Therapy in Patients with COPD: Considerations with Inhalers

January 4th 2023

Patient Education and Proper Inhaler Technique

January 4th 2023

Optimal Management of COPD: Escalation and De-escalation of Therapy

Podcasts
View All
November 16th 2021

A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs

August 26th 2017

Podcast: This Week in Managed Care - When to Start Mammography, and Other Health News

June 3rd 2017

Podcast: This Week in Managed Care - Fighting Medicare Fraud, and Other News

More News

Patient with psoriasis | Image Credit: Daniel Beckemeier
July 29th 2024

Study: Psoriasis Not an Independent Risk Factor for COPD Development

Brooke McCormick
Psoriasis is not an independent risk factor for developing chronic obstructive pulmonary disease (COPD), according to a new study.
Female patient receiving care from general practitioner | Image Credit: bongkarn - stock.adobe.com
July 22nd 2024

Patients With Intellectual Disabilities Face Distinct Challenges in COPD, Asthma Care

Brooke McCormick
Patients with intellectual disabilities experience inconsistent chronic obstructive pulmonary disease (COPD) consultations and higher rates of antibiotic prescriptions for asthma, highlighting the need for improved and tailored primary care management.
Hospital room | Image Credit: catinsyrup - stock.adobe.com
July 18th 2024

COPD Linked to Increased Mortality, Hospitalization Risk in Patients With HFpEF

Brooke McCormick
Chronic obstructive pulmonary disease (COPD) significantly heightens the risk of mortality and hospitalization in patients with heart failure with preserved ejection fraction (HFpEF).
Cityscape | Image Credit: leungchopan - stock.adobe.com
July 12th 2024

Study Finds Lower COPD Risk Among Patients Living in Cities With Fewer Than 50,000 Residents

Brooke McCormick
A Danish study found that living in cities with fewer than 50,000 residents and in newer, owned, and less dense homes is associated with a lower risk of developing chronic obstructive pulmonary disease (COPD).
what we're reading logo
July 2nd 2024

What We’re Reading: Shrinking Drug Coverage; Geriatric Care Training Investment; Escalated Patent Fight

AJMC Staff
Insurers continue to raise consumer costs despite covering fewer drugs and having more drug coverage restrictions; the Biden Administration is investing hundreds of millions of dollars to train geriatricians; the Federal Trade Commission has opened an investigation into Teva Pharmaceuticals after the company refused to take down patents for its asthma and chronic obstructive pulmonary disease inhalers.
AJMC with Dr Munaf Siyamwala | Background image credit: ipopba - stock.adobe.com
July 1st 2024

131 Million Americans Live in Areas With Dangerous Air Pollution Levels, Report Finds

Brooke McCormick
Based on the 2024 State of the Air report, Munaf Siyamwala, MD, of Centerpoint Medical Center, noted that patients with COPD need personalized action plans to manage flare-ups exacerbated by poor air quality and extreme weather conditions.
AJMC with Dr Munaf Siyamwala | Background image credit: ipopba - stock.adobe.com
June 29th 2024

Heatwaves and High Pollution: Dr Munaf Siyamwala on Challenges Patients With COPD Face During Summertime

Brooke McCormick
Munaf Siyamwala, MD, of Centerpoint Medical Center, explained that summertime heatwaves and increased pollution significantly exacerbate symptoms for patients with chronic obstructive pulmonary disease (COPD).
FDA approval | Image Credit: Olivier Le Moal - stock.adobe.com
June 26th 2024

FDA Approves Ensifentrine for Maintenance Treatment of Adult Patients With COPD

Brooke McCormick
Today, the FDA approved ensifentrine (Ohtuvayre; Verona Pharma) for the maintenance treatment of moderate to severe chronic obstructive pulmonary disease (COPD) based on the successful phase 3 ENHANCE trials.
Female patient using inhaler | Image Credit: DALU11 - stock.adobe.com
June 12th 2024

High Rates of Inhaler Misuse Found Among Patients With COPD Using Soft Mist Inhalers

Brooke McCormick
Misuse of soft mist inhalers (SMIs) is common among patients with chronic obstructive pulmonary disease (COPD), particularly those with low education levels, higher symptom scores, and a shorter disease duration.
COPD cartoon | Image credit: peterschreiber.media - stock.adobe.com
May 23rd 2024

Dupilumab Improves Pre-, Postbronchodilator Lung Function Measures in Patients With COPD, Type 2 Inflammation

Brooke McCormick
Two abstracts presented at the American Thoracic Society 2024 International Conference analyzed the phase 3 LIBERTY COPD BOREAS trial, finding that dupilumab improves pre- and post-bronchodilator lung function measures in patients with chronic obstructive pulmonary disease (COPD) and type 2 (T2) inflammation.
Doctor holding lung animation | Image Credit: mi_viri - stock.adobe.com
May 20th 2024

Patients With COPD, PRISm at Increased All-Cause, Cause-Specific Mortality Risk

Brooke McCormick
Patients with chronic obstructive pulmonary disease (COPD) and/or preserved ratio impaired spirometry (PRISm) have an increased risk of all-cause and cause-specific mortality, highlighting the need for better understanding of these conditions through increased spirometry data collection.
Heart animation | Image Credit: Siarhei - stock.adobe.com
May 16th 2024

Study: Italian Patients With COPD at High Risk of Severe Cardiovascular Events

Brooke McCormick
Italian patients with chronic obstructive pulmonary disease (COPD) face a significantly increased risk of severe cardiovascular events.
COPD drawing | Image Credit: Ivelin Radkov - stock.adobe.com
May 7th 2024

Low COPD Diagnosis Rate Among Japanese Patients Indicates Underdiagnosis

Brooke McCormick
There is an extremely low rate of chronic obstructive pulmonary disease (COPD) diagnoses in Japan, particularly among patients with airflow obstruction, despite regular respiratory function tests.
drawing of patient with anxiety | Image Credit: tadamichi - stock.adobe.com
May 2nd 2024

Study: Anxiety May Increase Acute Exacerbation Risk for Older Patients With COPD

Brooke McCormick
Older patients with chronic obstructive pulmonary disease (COPD) and anxiety exhibited exacerbated symptoms, increased comorbidities, and frequent acute exacerbations of COPD (AECOPD), emphasizing the need for routine psychiatric screening in COPD management.
Vitamin D | Image Credit: Katsiaryna Hatsak - stock.adobe.com
April 26th 2024

Vitamin D Supplementation Linked to Reduced In-Hospital, ICU Mortality in Patients With COPD

Brooke McCormick
Vitamin D supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease (COPD), a study found.
COPD | Image Credit: peterschreiber.media - stock.adobe.com
April 24th 2024

Patients With COPD, Muscle Loss Phenotype Face Increased Risk of All-Cause, COPD-Related Death

Brooke McCormick
Patients with chronic obstructive pulmonary disease (COPD) and muscle loss phenotype (MLP) have an elevated risk of all-cause or COPD-related mortality.
COPD exacerbation | Image Credit: RFBSIP - stock.adobe.com
April 22nd 2024

Patient-Reported Outcomes Help to Uncover Frailty Patterns in Those With Acute COPD Exacerbations

Brooke McCormick
Study findings demonstrate the pivotal role of patient-reported outcomes in identifying frailty among individuals experiencing acute exacerbations of chronic obstructive pulmonary disease (COPD).
Jhon Vargas | Image provided by author
April 15th 2024

Contributor: Profit Over People—Medicare Advantage Plans Are Denying Vital NIV Therapy Coverage

Jhon Vargas
A longtime respiratory therapist calls for reform of Medicare Advantage in light of denials of coverage for patients who need non-invasive ventilation.
BMI formula written on notepad | Image Credit: Vitalii Vodolazskyi - stock.adobe.com
April 10th 2024

Study: Decreased BMI Increases Severe Exacerbation, All-Cause Mortality Risk in Patients With COPD

Brooke McCormick
Decreased body mass index (BMI) in patients with chronic obstructive pulmonary disease (COPD) was linked to a higher risk of severe exacerbations and all-cause mortality, emphasizing the importance of monitoring BMI for managing COPD and predicting outcomes.
Inhaler | Image Credit: Andrzej Tokarski - stock.adobe.com
April 3rd 2024

Study: 1 in 6 US Patients With COPD Suffers From Cost-Related Medication Nonadherence

Brooke McCormick
Medication nonadherence among patients with chronic obstructive pulmonary disease (COPD) is associated with increasing COPD symptoms, hospitalizations, morbidity, mortality, and health care expenditures.
COPD animation | Image Credit: peterschreiber.media - stock.adobe.com
March 24th 2024

Dose-Escalation, Low-Dose Regimens May Improve Roflumilast Treatment Adherence in Patients With COPD

Brooke McCormick
This study suggests that dose-escalation or low-dose regimens for roflumilast treatment in patients with chronic obstructive pulmonary disease (COPD) may improve adherence.
man breaking cigarette in half | Image Credit: mbruxelle - stock.adobe.com
March 20th 2024

Smoking Reduction, Cessation Lowers Lung Cancer Risk in Patients With COPD

Brooke McCormick
Reducing or quitting smoking significantly lowered the risk of lung cancer in patients with chronic obstructive pulmonary disease (COPD) who smoked less than 30 pack-years in a recent study.
empty hospital bed | Image Credit: catinsyrup - stock.adobe.com
March 18th 2024

Similar In-Hospital, Long-Term Survival Rates Found Among Male, Female Patients With AECOPD

Brooke McCormick
This study analyzed sex differences among patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), with findings indicating that female smokers experience worse hospital outcomes despite similar overall survival rates.
Hospital bed | Image Credit: Gorodenkoff - stock.adobe.com
March 14th 2024

Admission Heart Rate Can Be Used as an In-Hospital Mortality Risk Marker in Patients With AECOPD, RF

Brooke McCormick
Results demonstrated a nonlinear relationship between admission heart rate (AHR) and in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and respiratory failure (RF).
depressed elderly patient | Image Credit: LIGHTFIELD STUDIOS - stock.adobe.com
March 8th 2024

Frailty, Depression Can Affect Social Support, Self-Management in Older Patients With COPD

Brooke McCormick
Self-management (SM) among older patients with chronic obstructive pulmonary disease (COPD) is moderately low, and frailty and depression may partially mediate the relationship between social support and SM in these patients.
hands cradling model of lungs | Image Credit: SewcreamStudio - stock.adobe.com
March 6th 2024

Study: Oxidative Balance Score Negatively Associated With Frailty in Patients With COPD

Brooke McCormick
In patients with chronic obstructive pulmonary disease (COPD), the higher the oxidative balance score, the lower the frailty risk, especially in women.
flat lining patient in hospital | Image Credit: kinomaster - stock.adobe.com
February 25th 2024

Study: High SII Linked With Increased Respiratory Failure, Death Risk in Patients With COPD

Brooke McCormick
The systemic immune-inflammation index (SII) was found to be a potential predictor of the prognosis of patients with chronic obstructive pulmonary disease (COPD).
3D illustration of heart | Image Credit: yodiyim - stock.adobe.com
February 20th 2024

Patients With COPD Using Triple Therapy Face Increased Cardiovascular Risk, Study Finds

Brooke McCormick
Patients with chronic obstructive pulmonary disease (COPD) on triple therapy face an increased cardiovascular risk.
Diverse group of people exercising | Image Credit: Rawpixel.com - stock.adobe.com
February 15th 2024

Sedentary Patients With COPD Have a Higher Risk of Emergency Department Visits, Study Says

Brooke McCormick
Patients with chronic obstructive pulmonary disease (COPD) and reduced physical activity showed a higher risk of emergency department visits or hospitalizations in a recent study.
woman smoking a cigarette | Image Credit: mitarart - stock.adobe.com
February 6th 2024

Ever-Smokers With COPD Have a Greater Risk of Developing ADHD, Study Says

Brooke McCormick
No causal association with psychiatric disorders was observed in patients with chronic obstructive pulmonary disease (COPD) without a smoking history, while ever-smokers with COPD had a greater risk of developing attention-deficit/hyperactivity disorder (ADHD).
12345678
...
25>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo